Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
Leukocyte extravasation: diapedesis
PSA
Free radical eliminators
Where you see Psammoma bodies

2. Gastric adenocacinoma
DPC gene
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
primary amyloidosis
bone malignant tumor

3. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)
blood cell malignant tumors
erb - B2 gene
benign epithelial tumor
p16 gene

4. Enzymes: catalase - superoxide dismutase - glutathione peroxidase.Vitamins: ACE Spontaneous decay
Free radical eliminators
acanthosis nigricans (hyperpig and epidermal thickening)
Neoplasm associated with actinic keratosis
ret gene

5. Breast cancer 13q tumor suppressor (DNA repair protein)
CCl4 target
fat benign tumor
Acute inflammatory mediators
BRAC2 gene

6. Malignant melanoma
Second - leading cause of death in the US
dysplastic nevus
extrinsic apoptosis
Paget's bone disease

7. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
lung cancer incidence/mortality
Napthalene (aniline) dyes target
Primary tumors that met to liver
intrinsic apoptosis

8. Liposarcoma
causes of decreased ESR
nitrosamines (smoked foods) target
fat malignant tumor
iron poisoning

9. Bacterial products (CLIK):C5a - LTB4 - IL-8 - Kallikrein
lung cancer incidence/mortality
ret gene
Leukocyte extravasation: migration
paraneoplastic effects of leukemias and lymphomas

10. Hyperuricemia (excess NA turnover)
nitrosamines (smoked foods) target
c - myc gene
paraneoplastic effects of leukemias and lymphomas
WT1 gene

11. Tumor marker: pancreatic adenocarcinoma
Pale infarcts
prostate cancer incidence/mortality
CA-19-9
Primary tumors that met to bone

12. Rhabdomyoma
CA-125
nitrosamines (smoked foods) target
Primary tumors that met to bone
skeletal muscle benign tumor

13. Squamous cell carcinoma of the esophagus
blood cell malignant tumors
prostate cancer incidence/mortality
TRAP
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)

14. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)
granulomatous disease
p53 gene
Paget's bone disease
erb - B2 gene

15. ADH
Reversible - plasias
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
Leading cause of death in the US
smooth muscle benign tumor

16. Tumor marker: ovarian - malignant epithelial tumors.
CA-125
Leukocyte extravasation: migration
Autoimmune (Hashimoto's - myasthenia gravis)
Second - leading cause of death in the US

17. Lung - liver - intestine or following reperfusion.
vinyl chloride target
Red (hemorrhagic) infarcts
ras gene
TRAP

18. Tumor marker: prostate carcinoma marker.
Prostatic acid phosphatase
lung cancer incidence/mortality
iron poisoning
paraneoplastic effects of thymoma - small cell lung carcinoma

19. Visceral malignancy (stomach - lung - breast - uterus)
acanthosis nigricans (hyperpig and epidermal thickening)
iron poisoning
aflatoxin target
c - myc gene

20. GIST cytokine receptor (oncogene)
PSA
c - kit gene
granulomatous disease
WT1 gene

21. Macrophages and lymphocytes. Persistant destruction and repair.
Chronic inflammatory mediators
benign epithelial tumor
cigarette smoke target
Necrosis

22. Tumor marker: mets to bone - obstructive biliary disease - Paget's
lung cancer incidence/mortality
causes of increased ESR
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
Alk - phos

23. Malignant lymphoma
immunodeficiency states
benign >1 cell type tumor
blood vessels malignant tumor
Necrosis

24. Tumor marker: thyroid medullary carcinoma
Resolution of inflammation
PSA
CA-19-9
calcitonin

25. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.
Barrett's esophagus (chronic GI reflux)
primary amyloidosis
alpha - fetoprotein
paraneoplastic effects of leukemias and lymphomas

26. Lipoma
Napthalene (aniline) dyes target
Barrett's esophagus (chronic GI reflux)
BRAC2 gene
fat benign tumor

27. Blood (leukemia)
Alkylating agents target
ras gene
calcitonin
Prostatic acid phosphatase

28. Lymphoma

29. Colon>stomach>pancreas>breast>lung (liver and lung are the most common places for mets)
causes of decreased ESR
Primary tumors that met to liver
vinyl chloride target
TRAP

30. Tumor marker: neuroblastoma - lung and gastric cancer
Bombesin
malignant epithelial tumor
Primary tumors that met to bone
causes of decreased ESR

31. Mature teratoma in men or malignant teratoma in M/F
prostate cancer incidence/mortality
arsenic target
Where you see Psammoma bodies
malignant >1 cell type tumor

32. All - AML
paraneoplastic effects of small cell lung carcinoma
Neoplasm associated with Down Syndrome
primary amyloidosis
Leukocyte extravasation: diapedesis

33. MEN type II and III tyrosine kinase (oncogene)
CCl4 target
p16 gene
ret gene
bone benign tumor

34. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
acanthosis nigricans (hyperpig and epidermal thickening)
Necrosis
Chronic inflammatory mediators
CEA

35. Osteosarcoma
extrinsic apoptosis
bone malignant tumor
radiation exposure
primary amyloidosis

36. Aggressive malignant lymphomas (non - Hodgkin's) and Kaposi's sarcoma
Free radical cell damage
Prostatic acid phosphatase
AIDS
blood cell malignant tumors

37. Liver (centrilobular necrosis - fatty change)
immunodeficiency states
CCl4 target
granulomatous disease
causes of decreased ESR

38. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
Neoplasm associated with Down Syndrome
Red (hemorrhagic) infarcts
malignant >1 cell type tumor
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)

39. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
vinyl chloride target
NF2 gene
AIDS
Leading cause of death in the US

40. Rhabdomyosarcoma
skeletal muscle malignant tumor
Second - leading cause of death in the US
L- myc gene
Acute inflammatory mediators

41. Larynx (SqCC) - lung (SqCC and SCC) - kidney (renal cell carcinoma) - bladder (transitional cell carcinoma)
Primary tumors that met to bone
blood vessels malignant tumor
ras gene
cigarette smoke target

42. Bladder (transitional cell carcinoma)
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
Irreversible - plasias
Bombesin
Napthalene (aniline) dyes target

43. Lung (mesothelioma and bronchogenic carcinoma)
arsenic target
Where you see Psammoma bodies
asbestos target
Primary tumors that met to bone

44. Neuroblastoma transcription factor (oncogene)
immunodeficiency states
secondary amyloidosis (reactive systemic)
N- myc gene
APC gene

45. Burkitt's lymphoma transcription factor (oncogene)
c - myc gene
Neoplasm associated with actinic keratosis
Rb gene
causes of decreased ESR

46. Liver (angiosarcoma)
alpha - fetoprotein
BRCA1 gene
Leading cause of death in the US
vinyl chloride target

47. Secondary osteosarcoma and fibrosarcoma

48. Erythropoietin
CEA
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
cirrosis (alcohol - hepB or C)
Neoplasm associated with actinic keratosis

49. Osteoma
bone benign tumor
fat benign tumor
TRAP
Free radical eliminators

50. Angiosarcoma
Acute inflammatory mediators
blood vessels malignant tumor
Napthalene (aniline) dyes target
bone malignant tumor